Why the study?
Does percutaneous aortic balloon valvuloplasty provide sustained clinical and hemodynamic benefits in elderly patients with severe calcific aortic stenosis?
Does percutaneous aortic balloon valvuloplasty provide sustained clinical and hemodynamic benefits in elderly patients with severe calcific aortic stenosis?
Percutaneous aortic balloon valvuloplasty in elderly patients with severe calcific aortic stenosis provides only short-lived hemodynamic and clinical benefits with a high restenosis rate, suggesting it should be reserved as a bridge to surgery or for truly inoperable cases.
Answers are grounded in this paper and cite their sources.
High restenosis rate may limit durability in severe calcific aortic stenosis; leaves open bridge-to-surgery role pending randomized trials.
In order to evaluate the short- and mid-term results of percutaneous aortic balloon valvuloplasty, 40 consecutive elderly patients, who had undergone balloon valvuloplasty for calcific aortic stenosis, were prospectively followed up by means of clinical and echo-Doppler examinations. Although valvuloplasty often dramatically improves hemodynamics and relieves symptoms, these benefits seem to be short-lived in most cases. Restenosis, defined as a loss of 50% or more of the increase in aortic valve area obtained by the dilatation, has a very high rate of occurrence. Aortic balloon valvuloplasty should therefore be reserved for truly inoperable cases and can be performed in hemodynamically unstable patients, who may later undergo surgery.
No takes yet. Share an insight, caveat, or question.
Chioin et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: